The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

Purpose. To assess the morphology of idiopathic choroidal neovascularization (ICNV) by optical coherence tomography angiography (OCTA) and determine the therapeutic effects of intravitreal antivascular endothelial growth factor (anti-VEGF). Method. Patients with naive ICNV were assessed by spectral...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qin Chen, Xiaobing Yu, Zihan Sun, Hong Dai
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2016/5608250
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization
by: Jing-Yao Liu, et al.
Published: (2025-09-01)

Efficacy and prognostic factors of anti-VEGF treatment for neovascular age-related macular degeneration: An OCTA imaging-based deep learning analysis
by: Shengnan Liu, et al.
Published: (2025-10-01)

Multiple serous retinal detachments after Anti-VEGF Intravitreal Injection for pachychoroid related choroidal neovascularization
by: Huilin Liang, et al.
Published: (2024-12-01)

Comparative study between swept-source and spectral-domain OCTA for imaging of choroidal neovascularization in age-related macular degeneration
by: Ji-Xian Ma, et al.
Published: (2024-11-01)

Idiopathic Choroidal Neovascular Membrane In Young Treated With Minimum Anti Vascular Endothelial Growth Factor
by: Rahul Kumar Sharma, et al.
Published: (2017-10-01)

Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy
by: Ryan B. Rush, et al.
Published: (2015-01-01)

Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
by: Richard H Foxton, et al.
Published: (2019-04-01)

Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA
by: Anna Heinke, et al.
Published: (2025-06-01)

Optical Coherence Tomography Angiography (OCTA) information content in the diagnosis of type 1 choroidal neovascularization combined with pigment epithelium detachment
by: V. V. Neroev, et al.
Published: (2021-03-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01)

Choroidal Osteoma with Choroidal Neovascularization and Focal Choroidal Excavation
by: Rajwinder Kaur, et al.
Published: (2021-10-01)

Efficiency of antiangiogenic therapy for choroidal neovascularization in children
by: L. A. Katargina, et al.
Published: (2024-12-01)

Impact of photodynamic therapy combined with Anti-VEGF vs. Anti-VEGF monotherapy on choriocapillaris vessel density in polypoidal choroidal vasculopathy
by: Po-Chin Kuo, et al.
Published: (2025-04-01)

THE ROLE OF ANTI-VEGF THERAPY IN IMPROVING THE EFFICACY OF SURGICAL TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA
by: Uliana Sydorchuk, et al.
Published: (2024-10-01)

Double focal choroidal excavation with choroidal neovascularization
by: Sashwanthi Mohan, et al.
Published: (2025-01-01)

Bilateral Multifocal Choroidal Osteoma with Choroidal Neovascularization
by: Mousavi MirNaghi, et al.
Published: (2015-01-01)

Short-term effect of anti-VEGF for chronic central serous chorioretinopathy according to the presence of choroidal neovascularization using optical coherence tomography angiography.
by: Yong-Yeon Song, et al.
Published: (2021-01-01)

CLINICAL EFFECTIVENESS OF NEUROTRANSMITTERS PATIENTS WITH PRIMARY GLAUCOMA VEGF INHIBITOR IN PATIENTS WITH CHOROIDAL NEOVASCULARIZATION CAUSED BY DEGENERATIVE MYOPIA
by: L. P. Danilova, et al.
Published: (2016-09-01)

Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization
by: Xiaoli Zhang, et al.
Published: (2020-01-01)

Atypical choroidal neovascular membrane
by: Kimia Rezaei, et al.
Published: (2024-12-01)

A New Anti-VEGF Inhibitor, Aflibercept: Treatment Outcomes Of Neovascular Macular Degeneration Refractory To Other Anti-VEGF Agents
by: Kiran Turaka
Published: (2014-04-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation
by: Xi Chen, et al.
Published: (2024-07-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01)

Analysis of intravitreal using of anti vegf-medications for diseases of fundus accompanied by exudation and neovascularization
by: N. G. Zavgorodnya, et al.
Published: (2013-08-01)

Clinical features of focal choroidal excavation subtypes and their association with choroidal neovascularization
by: Yuhong Gan, et al.
Published: (2025-06-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Predicting response to anti-VEGF therapy in neovascular age-related macular degeneration using random forest and SHAP algorithms
by: Peng Zhang, et al.
Published: (2025-06-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Myopic choroidal neovascularization with dilated choroid vessels is prone to progression into subretinal fibrosis following anti-vascular endothelial growth factor therapy: a retrospective study
by: Xiangjun She, et al.
Published: (2025-08-01)

Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes
by: Sean D. Adrean, et al.
Published: (2017-01-01)

Indications of the SERPINE 1 variant rs1799768's role in anti-VEGF therapy resistance in neovascular age-related macular degeneration.
by: Muhammer Özgür Çevik, et al.
Published: (2025-01-01)

Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD
by: Miltiadis K. Tsilimbaris, et al.
Published: (2016-01-01)

Analysis of OCT predictors of anatomical and functional results of anti-VEGF therapy of pigment epithelium detachment in neovascular age-related macular degeneration
by: E.V. Kozina, et al.
Published: (2024-06-01)

Genotype-specific retinal and choroidal perfusion patterns in inherited retinal diseases: an SS-OCTA analysis
by: Yu Rong, et al.
Published: (2025-07-01)

Predicting long-term functional anti-VEGF treatment outcomes in neovascular AMD in a real-world setting.
by: Isabel B Pfister, et al.
Published: (2024-01-01)

Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study
by: Mekala Shellvarajah, et al.
Published: (2025-04-01)